Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Citi
US Department of Justice
Dow
Medtronic
AstraZeneca
Argus Health
Cipla
Moodys

Generated: January 22, 2018

DrugPatentWatch Database Preview

Upsher Smith Company Profile

« Back to Dashboard

What is the competitive landscape for UPSHER SMITH, and what generic and branded alternatives to UPSHER SMITH drugs are available?

UPSHER SMITH has eight approved drugs.



Summary for Upsher Smith
US Patents:0
Tradenames:5
Ingredients:5
NDAs:8

Drugs and US Patents for Upsher Smith

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith PREDNISONE prednisone TABLET;ORAL 087471-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher Smith METHOCARBAMOL methocarbamol TABLET;ORAL 087453-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher Smith METHOCARBAMOL methocarbamol TABLET;ORAL 087454-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher Smith DEXAMETHASONE dexamethasone TABLET;ORAL 087534-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher Smith SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087553-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher Smith DEXAMETHASONE dexamethasone TABLET;ORAL 087533-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher Smith PREDNISONE prednisone TABLET;ORAL 087470-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher Smith SPIRONOLACTONE spironolactone TABLET;ORAL 087554-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
McKesson
Federal Trade Commission
Deloitte
Fish and Richardson
Daiichi Sankyo
Covington
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot